Citation Impact
Citing Papers
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
2009 Standout
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 Standout
Sulfur [ 18 F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis
2021 StandoutNobel
Oral cavity and oropharyngeal squamous cell carcinoma—an update
2015 Standout
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
2011 Standout
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials
2011 Standout
Head and neck squamous cell carcinoma
2020 Standout
Phase II Study of Risk-Adapted Therapy of Newly Diagnosed, Aggressive Non-Hodgkin Lymphoma Based on Midtreatment FDG-PET Scanning
2009
Histopathology of Gastric and Duodenal Strongyloides stercoralis Locations in Fifteen Immunocompromised Subjects
2006
Phase I and II trials of novel anti-cancer agents: Endpoints, efficacy and existentialism
1998
Molecular imaging in drug development
2008 Standout
Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial
2002
Treatment of patients with advanced gastric carcinoma with a 5-fluorouracil-based or a cisplatin-based regimen
1998
Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin’s disease
2002
Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer
1995
Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin’s lymphoma (NHL)
2001
FDG PET and high-dose therapy for aggressive lymphomas: toward a risk-adapted strategy
2004
Postmastectomy Irradiation in High-Risk Breast Cancer Patients: Present status of the Danish Breast Cancer Cooperative Group trials
1988
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 Standout
Early 18F-FDG PET for Prediction of Prognosis in Patients with Diffuse Large B-Cell Lymphoma: SUV-Based Assessment Versus Visual Analysis
2007
Head and neck cancer
2008 Standout
Prognostic value of positron emission tomography in the evaluation of post‐treatment residual mass in patients with Hodgkin's disease and non‐Hodgkin's lymphoma
2001
Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast Cancer
2002 Standout
Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: Report from the DAHANCA 2 study
1989
Two cases of fatal strongyloidiasis in Hong Kong
1997
Meta-DiSc: a software for meta-analysis of test accuracy data
2006 Standout
3D Slicer as an image computing platform for the Quantitative Imaging Network
2012 Standout
Exploiting tumour hypoxia in cancer treatment
2004 Standout
Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer
2002 Standout
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Adverse Effects of Long-Term Proton Pump Inhibitor Therapy
2011
Imaging of the lymphatic system: new horizons
2006
A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003
2000 Standout
FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin’s lymphoma and Hodgkin’s disease
2006
Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients
2006
Early therapeutic response assessment by18FDG-positron emission tomography during chemotherapy in patients with diffuse large B-cell lymphoma: Isolated residual positivity involving bone is not usually a predictor of subsequent treatment failure
2007
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer
1996
Clinical molecular imaging with positron emission tomography
2006
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
2010 Standout
Early complete response during chemotherapy predicts favorable outcome in patients with primary CNS lymphoma
2010
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Microenvironmental regulation of metastasis
2008 Standout
Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy
1997 Standout
Primary brain tumours in adults
2012 Standout
Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers
2006
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
2003 Standout
Strongyloides hyperinfection in two patients with lymphoma, purulent meningitis, and sepsis
1991
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
2014 Standout
Overview of early response assessment in lymphoma with FDG-PET
2007
Radiosensitivity and effect of hypoxia in HPV positive head and neck cancer cells
2013
Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas
1995
FDG PET and risk-adapted therapy in Hodgkin's and non-Hodgkin's lymphoma
2008
Head and Neck Cancer
2001 Standout
Computed tomography and 18F-FDG positron emission tomography for therapy control of Hodgkin's and non-Hodgkin's lymphoma patients: when do we really need FDG-PET?
2005
Imaging in staging of malignant lymphoma: a systematic review
2007
FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma
2005
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Clearance Properties of Nano-Sized Particles and Molecules as Imaging Agents: Considerations and Caveats
2008 Standout
Five-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Segmental Mastectomy with or without Radiation in the Treatment of Breast Cancer
1985 Standout
18F-fluoro-deoxyglucose positron emission tomography for post-treatment evaluation of malignant lymphoma: a systematic review.
2006
Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer.
1987
Increasing frequency of acute myeloid leukemia complicating Hodgkin's disease: A review
1980
Revised Response Criteria for Malignant Lymphoma
2007 Standout
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP
2006 Standout
Positron Emission Tomography As an Imaging Biomarker
2006
Human and Animal Dirofilariasis: the Emergence of a Zoonotic Mosaic
2012 Standout
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
Clinical trials of radiosensitizers: What should we expect?
1984
Chemotherapy for advanced gastric cancer
2017 Standout
[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome
2005
PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease.
2002
Diffuse large cell lymphoma
2011
Strongyloides stercoralisin the Immunocompromised Population
2004 Standout
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
18F-FDG PET/CT Imaging In Oncology
2011
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
2005
The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease.
2006
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
Diffusion-Weighted MRI in the Body: Applications and Challenges in Oncology
2007 Standout
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's disease.
1987 StandoutNobel
Comparing Radical Mastectomy with Quadrantectomy, Axillary Dissection, and Radiotherapy in Patients with Small Cancers of the Breast
1981 Standout
Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma
2008
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Integrating PET and PET/CT into the risk-adapted therapy of lymphoma.
2007
Mutation of the gastric hydrogen-potassium ATPase alpha subunit causes iron-deficiency anemia in mice
2011 StandoutNobel
Works of A.R. Timothy being referenced
Strongyloides stercoralis hyperinfection associated with cimetidine in an immunosuppressed patient: diagnosis by endoscopic biopsy.
1986
Radiotherapy in the treatment of Hodgkin's disease.
1978
Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse
2000
Radiotherapy for Inoperable Lung Cancer
2001
Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma
2005
Fluorodeoxyglucose positron emission tomography in the initial staging of germ cell tumours
2000
A single-blind, randomised, vehicle-controlled dose-finding study of recombinant human granulocyte colony-stimulating factor (lenograstim) in patients undergoing chemotherapy for solid cancers and lymphoma
1995
FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma
2005
18-FDG-PET as a Prognostic Indicator in the Treatment of Aggressive Non-Hodgkin's Lymphoma-Comparison with CT
2000
Appropriate chemotherapy for palliating advanced cancer.
1992
Studies of the pharmacokinetic properties of nimorazole
1983
A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo
1982
18-FDG-PET for the assessment of residual masses on CT following treatment of lymphomas
2000
2000
A phase I clinical study of nimorazole as a hypoxic radiosensitizer
1984
TREATMENT OF EARLY CARCINOMA OF THE BREAST
1979
PET scanning in clinical oncology
1998